• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源和鼠源醛酮还原酶 AKR1B 亚家族及其与视黄醛的特异性。

Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.

机构信息

Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Barcelona, Spain.

出版信息

Chem Biol Interact. 2011 May 30;191(1-3):199-205. doi: 10.1016/j.cbi.2011.02.007. Epub 2011 Feb 15.

DOI:10.1016/j.cbi.2011.02.007
PMID:21329680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3103653/
Abstract

NADP(H)-dependent cytosolic aldo-keto reductases (AKR) are mostly monomeric enzymes which fold into a typical (α/β)(8)-barrel structure. Substrate specificity and inhibitor selectivity are determined by interaction with residues located in three highly variable loops (A, B, and C). Based on sequence identity, AKR have been grouped into families, namely AKR1-AKR15, containing multiple subfamilies. Two human enzymes from the AKR1B subfamily (AKR1B1 and AKR1B10) are of special interest. AKR1B1 (aldose reductase) is related to secondary diabetic complications, while AKR1B10 is induced in cancer cells and is highly active with all-trans-retinaldehyde. Residues interacting with all-trans-retinaldehyde and differing between AKR1B1 and AKR1B10 are Leu125Lys and Val131Ala (loop A), Leu301Val, Ser303Gln, and Cys304Ser (loop C). Recently, we demonstrated the importance of Lys125 as a determinant of AKR1B10 specificity for retinoids. Residues 301 and 304 are also involved in interactions with substrates or inhibitors, and thus we checked their contribution to retinoid specificity. We also extended our study with retinoids to rodent members of the AKR1B subfamily: AKR1B3 (aldose reductase), AKR1B7 (mouse vas deferens protein), AKR1B8 (fibroblast-growth factor 1-regulated protein), and AKR1B9 (Chinese hamster ovary reductase), which were tested against all-trans isomers of retinaldehyde and retinol. All enzymes were active with retinaldehyde, but with k(cat) values (0.02-0.52 min(-1)) much lower than that of AKR1B10 (27 min(-1)). None of the enzymes showed oxidizing activity with retinol. Since these enzymes (except AKR1B3) have Lys125, other residues should account for retinaldehyde specificity. Here, by using site-directed mutagenesis and molecular modeling, we further delineate the contribution of residues 301 and 304. We demonstrate that besides Lys125, Ser304 is a major structural determinant for all-trans-retinaldehyde specificity of AKR1B10.

摘要

NADP(H)-依赖的细胞质醛酮还原酶 (AKR) 大多是单体酶,它们折叠成典型的 (α/β)(8)-桶状结构。底物特异性和抑制剂选择性由与位于三个高度可变环 (A、B 和 C) 中的残基相互作用决定。根据序列同一性,AKR 已被分为家族,即 AKR1-AKR15,包含多个亚家族。AKR1B 亚家族的两种人类酶 (AKR1B1 和 AKR1B10) 特别引人注目。AKR1B1(醛糖还原酶)与二级糖尿病并发症有关,而 AKR1B10 在癌细胞中诱导,对全反式视黄醛具有高度活性。与 AKR1B1 和 AKR1B10 相互作用并不同的残基是 Leu125Lys 和 Val131Ala(环 A)、Leu301Val、Ser303Gln 和 Cys304Ser(环 C)。最近,我们证明了 Lys125 作为 AKR1B10 对类视黄醇特异性的决定因素的重要性。残基 301 和 304 也参与与底物或抑制剂的相互作用,因此我们检查了它们对类视黄醇特异性的贡献。我们还将我们的研究扩展到 AKR1B 亚家族的啮齿动物成员:AKR1B3(醛糖还原酶)、AKR1B7(小鼠输精管蛋白)、AKR1B8(成纤维细胞生长因子 1 调节蛋白)和 AKR1B9(中国仓鼠卵巢还原酶),它们都针对全反式视黄醛和视黄醇的异构体进行了测试。所有酶都对视黄醛有活性,但 k(cat) 值(0.02-0.52 min(-1))远低于 AKR1B10(27 min(-1))。没有一种酶对视黄醇表现出氧化活性。由于这些酶(AKR1B3 除外)都有 Lys125,其他残基应该是视黄醛特异性的原因。在这里,我们通过定点突变和分子建模,进一步描绘了残基 301 和 304 的贡献。我们证明,除了 Lys125 之外,Ser304 也是 AKR1B10 全反式视黄醛特异性的主要结构决定因素。

相似文献

1
Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.人源和鼠源醛酮还原酶 AKR1B 亚家族及其与视黄醛的特异性。
Chem Biol Interact. 2011 May 30;191(1-3):199-205. doi: 10.1016/j.cbi.2011.02.007. Epub 2011 Feb 15.
2
Engineering aldo-keto reductase 1B10 to mimic the distinct 1B15 topology and specificity towards inhibitors and substrates, including retinoids and steroids.工程化醛酮还原酶 1B10,以模拟其独特的 1B15 拓扑结构和对抑制剂和底物(包括类视黄醇和甾体)的特异性。
Chem Biol Interact. 2019 Jul 1;307:186-194. doi: 10.1016/j.cbi.2019.04.030. Epub 2019 Apr 24.
3
Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels.AKR1B亚家族的醛酮还原酶:类视黄醇特异性与细胞视黄酸水平的调控
Chem Biol Interact. 2009 Mar 16;178(1-3):171-7. doi: 10.1016/j.cbi.2008.10.027. Epub 2008 Oct 25.
4
Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.肿瘤标志物AKR1B10高全反式视黄醛还原酶活性的结构基础
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9. doi: 10.1073/pnas.0705659105. Epub 2007 Dec 17.
5
Characterization of AKR1B16, a novel mouse aldo-keto reductase.新型小鼠醛糖酮还原酶AKR1B16的特性分析
Chem Biol Interact. 2017 Oct 1;276:182-193. doi: 10.1016/j.cbi.2017.03.007. Epub 2017 Mar 18.
6
Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.醛酮还原酶1B15的底物特异性、抑制剂选择性及结构-功能关系:一种新型人类视黄醛还原酶
PLoS One. 2015 Jul 29;10(7):e0134506. doi: 10.1371/journal.pone.0134506. eCollection 2015.
7
Aldo-keto reductases in retinoid metabolism: search for substrate specificity and inhibitor selectivity.醛酮还原酶在类视黄醇代谢中的作用:寻找底物特异性和抑制剂选择性。
Chem Biol Interact. 2013 Feb 25;202(1-3):186-94. doi: 10.1016/j.cbi.2012.11.014. Epub 2012 Dec 3.
8
Selectivity determinants of inhibitor binding to the tumour marker human aldose reductase-like protein (AKR1B10) discovered from molecular docking and database screening.从分子对接和数据库筛选中发现的肿瘤标志物人醛糖还原酶样蛋白(AKR1B10)抑制剂结合的选择性决定因素。
Eur J Med Chem. 2010 Sep;45(9):4354-7. doi: 10.1016/j.ejmech.2010.05.032. Epub 2010 May 20.
9
Biological role of aldo-keto reductases in retinoic Acid biosynthesis and signaling.醛酮还原酶在视黄酸生物合成及信号传导中的生物学作用
Front Pharmacol. 2012 Apr 17;3:58. doi: 10.3389/fphar.2012.00058. eCollection 2012.
10
Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design.鉴定一种新型多氟化合物作为抑制人类醛糖还原酶和AKR1B10的先导物:三元复合物的结构测定及其对药物设计的意义。
Acta Crystallogr D Biol Crystallogr. 2014 Mar;70(Pt 3):889-903. doi: 10.1107/S1399004713033452. Epub 2014 Feb 27.

引用本文的文献

1
The aldose reductase inhibitors AT-001, AT-003 and AT-007 attenuate human keratinocyte senescence.醛糖还原酶抑制剂AT - 001、AT - 003和AT - 007可减轻人类角质形成细胞的衰老。
Front Aging. 2024 Dec 17;5:1466281. doi: 10.3389/fragi.2024.1466281. eCollection 2024.
2
Aldo-keto reductase (AKR) superfamily website and database: An update.醛酮还原酶(AKR)超家族网站和数据库:更新。
Chem Biol Interact. 2024 Aug 1;398:111111. doi: 10.1016/j.cbi.2024.111111. Epub 2024 Jun 13.
3
Identification of a Selective SCoR2 Inhibitor That Protects Against Acute Kidney Injury.

本文引用的文献

1
Rat aldose reductase-like protein (AKR1B14) efficiently reduces the lipid peroxidation product 4-oxo-2-nonenal.大鼠醛糖还原酶样蛋白(AKR1B14)能有效降低脂质过氧化产物 4-氧代-2-壬烯醛。
Biol Pharm Bull. 2010;33(11):1886-90. doi: 10.1248/bpb.33.1886.
2
Properties and tissue distribution of a novel aldo-keto reductase encoding in a rat gene (Akr1b10).一种新型醛酮还原酶(Akr1b10)在大鼠基因中的特性和组织分布。
Arch Biochem Biophys. 2010 Nov 15;503(2):230-7. doi: 10.1016/j.abb.2010.08.010. Epub 2010 Aug 13.
3
Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals.
鉴定一种选择性 SCoR2 抑制剂,该抑制剂可预防急性肾损伤。
J Med Chem. 2023 Apr 27;66(8):5657-5668. doi: 10.1021/acs.jmedchem.2c02089. Epub 2023 Apr 7.
4
New Insight into the Pharmacological Importance of Atropine as the Potential Inhibitor of AKR1B1 via Detailed Computational Investigations: DFTs, ADMET, Molecular Docking, and Molecular Dynamics Studies.深入探讨阿托品作为 AKR1B1 潜在抑制剂的药理学重要性:通过详细的计算研究:DFTs、ADMET、分子对接和分子动力学研究。
Appl Biochem Biotechnol. 2023 Aug;195(8):5136-5157. doi: 10.1007/s12010-023-04411-2. Epub 2023 Feb 27.
5
Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition.人类醛酮还原酶1B10抑制作用的结构基础透视
Metabolites. 2021 Dec 13;11(12):865. doi: 10.3390/metabo11120865.
6
Physiological and Pathological Roles of Aldose Reductase.醛糖还原酶的生理和病理作用
Metabolites. 2021 Sep 27;11(10):655. doi: 10.3390/metabo11100655.
7
Retinyl esters are elevated in progeny of retinol dehydrogenase 11 deficient dams.视黄醇脱氢酶 11 缺陷型母鼠的后代中视黄基酯升高。
Chem Biol Interact. 2019 Apr 1;302:117-122. doi: 10.1016/j.cbi.2019.01.041. Epub 2019 Feb 4.
8
Aldo-Keto Reductases 1B in Adrenal Cortex Physiology.醛酮还原酶1B在肾上腺皮质生理学中的作用
Front Endocrinol (Lausanne). 2016 Jul 22;7:97. doi: 10.3389/fendo.2016.00097. eCollection 2016.
9
RNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome.RNA测序揭示了小鼠肝脏转录组中常见和独特的孕烷X受体及组成型雄烷受体靶基因特征。
Biochim Biophys Acta. 2016 Sep;1859(9):1198-1217. doi: 10.1016/j.bbagrm.2016.04.010. Epub 2016 Apr 23.
10
Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase.醛酮还原酶1B15的底物特异性、抑制剂选择性及结构-功能关系:一种新型人类视黄醛还原酶
PLoS One. 2015 Jul 29;10(7):e0134506. doi: 10.1371/journal.pone.0134506. eCollection 2015.
吸烟诱导健康个体气道上皮中 AKR1B10 的表达上调。
Chest. 2010 Dec;138(6):1402-10. doi: 10.1378/chest.09-2634. Epub 2010 Aug 12.
4
Selectivity determinants of inhibitor binding to the tumour marker human aldose reductase-like protein (AKR1B10) discovered from molecular docking and database screening.从分子对接和数据库筛选中发现的肿瘤标志物人醛糖还原酶样蛋白(AKR1B10)抑制剂结合的选择性决定因素。
Eur J Med Chem. 2010 Sep;45(9):4354-7. doi: 10.1016/j.ejmech.2010.05.032. Epub 2010 May 20.
5
Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid.抗炎性 N-苯丙氨酸和甘草次酸对肿瘤标志物 AKR1B10 的选择性抑制。
Biol Pharm Bull. 2010;33(5):886-90. doi: 10.1248/bpb.33.886.
6
Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.肝癌治疗靶点的联合功能基因组研究。
Clin Cancer Res. 2010 May 1;16(9):2518-28. doi: 10.1158/1078-0432.CCR-09-2214. Epub 2010 Apr 13.
7
Aldo-keto reductase (AKR) superfamily: genomics and annotation.醛酮还原酶(AKR)超家族:基因组学与注释
Hum Genomics. 2009 Jul;3(4):362-70. doi: 10.1186/1479-7364-3-4-362.
8
Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis.双去甲氧基姜黄素对肿瘤标志物AKR1B10的强效选择性抑制作用:通过分子模拟和定点诱变探究该酶的活性位点
Biochem Biophys Res Commun. 2009 Nov 6;389(1):128-32. doi: 10.1016/j.bbrc.2009.08.107. Epub 2009 Aug 23.
9
Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels.AKR1B亚家族的醛酮还原酶:类视黄醇特异性与细胞视黄酸水平的调控
Chem Biol Interact. 2009 Mar 16;178(1-3):171-7. doi: 10.1016/j.cbi.2008.10.027. Epub 2008 Oct 25.
10
The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.醛酮还原酶超家族及其在药物代谢和解毒中的作用。
Drug Metab Rev. 2008;40(4):553-624. doi: 10.1080/03602530802431439.